Publications by authors named "Mark A A Claassen"

Claim this Profile
P
Prediction of Hepatocellular Carcinoma and Other Liver-Related Events in Chronic Hepatitis B Patients With Metabolic Dysfunction or Metabolic Dysfunction-Associated Steatotic Liver Disease.
Lesley A Patmore, Ivana Carey, Jordan J Feld, Willem P Brouwer, Keyur Patel, Mark A A Claassen

Aliment Pharmacol Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Socio-Economic, Behavioural and Clinical Factors on Liver Disease Progression in Individuals With HIV and Hepatitis B.
Clémence Ramier, Anders Boyd, Colette Smit, Rosan van Zoest, Mark A A Claassen

Liver Int· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus: DUALING Prospective Nationwide Matched Cohort Study.
Marta Vasylyev, Ferdinand W N M Wit, Carlijn C E Jordans, Robin Soetekouw, Steven F L van Lelyveld, Mark A A Claassen

Open Forum Infect Dis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe.
Lesley A Patmore, Kirsi M A van Eekhout, Maria Buti, Özgur M Koc, Kosh Agarwal, Mark A A Claassen

J Hepatol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of Low-Level Viremia and Immune Activation after Switching to a Darunavir-Based Regimen.
Arjen J Stam, Ninée V E J Buchholtz, Wouter F W Bierman, Reinout van Crevel, Andy I M Hoepelman, Mark A A Claassen

Viruses· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to use quality indicators for antimicrobial stewardship in your hospital: a practical example on outpatient parenteral antimicrobial therapy.
Ralf Stemkens, Jeroen A Schouten, Sophie A M van Kessel, Reinier P Akkermans, Denise S C Telgt, Mark A A Claassen

Clin Microbiol Infect· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent Transmission of HCV among Men Who Have Sex with Men despite Widespread Screening and Treatment with Direct-Acting Antivirals.
Stephanie Popping, Lize Cuypers, Mark A A Claassen, Guido E van den Berk, Anja De Weggheleire

Viruses· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical practice of hepatitis B screening in patients starting with chemotherapy: A survey among Dutch oncologists.
Karin Leber, Hans-Martin J M M B Otten, Dees P M Brandjes, Mark A A Claassen, Fanny N Lauw

Eur J Cancer Care (Engl)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study.
Colette Smit, Anders Boyd, Bart J A Rijnders, Thijs J W van de Laar, Eliane M Leyten, Mark A A Claassen

Lancet HIV· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial.
Anne Boerekamps, Anja De Weggheleire, Guido E van den Berk, Fanny N Lauw, Mark A A Claassen

Lancet Gastroenterol Hepatol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased overall survival after introduction of structured bedside consultation in Staphylococcus aureus bacteraemia.
Maud B P A Ariaans, Elisabeth A Roovers, Mark A A Claassen, Robert-Jan Hassing, Caroline M A Swanink

Eur J Clin Microbiol Infect Dis· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of latent tuberculous infection among HIV-infected patients in a Dutch out-patient clinic.
Petra van Bentum, Caroline M A Swanink, Ellen G van Lochem, Mark A A Claassen, Elisabeth H Gisolf

Int J Tuberc Lung Dis· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal-associated invariant T-cell frequency and function in blood and liver of HCV mono- and HCV/HIV co-infected patients with advanced fibrosis.
Boris J B Beudeker, Gertine W van Oord, Joop E Arends, Julian Schulze Zur Wiesch, Marieke S van der Heide, Mark A A Claassen

Liver Int· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune activation in prolonged cART-suppressed HIV patients is comparable to that of healthy controls.
Lennert van den Dries, Mark A A Claassen, Zwier M A Groothuismink, Eric van Gorp, Andre Boonstra

Virology· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Case | A patient with antineutrophil cytoplasmic antibody-positive vasculitis on treatment with fever and leucopenia.
Maya Kemps, Jacobien C Verhave, Mark A A Claassen, Janneke Ruinemans-Koerts, Ellen van der Spek

Kidney Int· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and HCV/HIV Co-Infection and Do Not Recover during Therapy.
Michelle Spaan, Sebastiaan J Hullegie, Boris J B Beudeker, Kim Kreefft, Gertine W van Oord, Mark A A Claassen

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased pro-inflammatory immune responses during recurrent acute HCV infections in HIV co-infected patients.
Sebastiaan J Hullegie, Joop E A Arends, Zwier M A Groothuismink, Suzan D Pas, Bart J A Rijnders, Mark A A Claassen

J Gen Virol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Boceprevir, peginterferon and ribavirin for acute hepatitis C in HIV infected patients.
Sebastiaan J Hullegie, Mark A A Claassen, Guido E L van den Berk, Jan T M van der Meer, Dirk Posthouwer

J Hepatol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of rilpivirine and boceprevir coadministration in HIV-infected patients treated for acute hepatitis C virus infection.
Sebastiaan J Hullegie, Brenda C M de Winter, Dirk Posthouwer, Peter P Koopmans, Mark A A Claassen

AIDS· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Intrahepatic T Cell Compartment Does Not Normalize Years After Therapy-Induced Hepatitis C Virus Eradication.
Michelle Spaan, Mark A A Claassen, Jun Hou, Harry L A Janssen, Robert J de Knegt

J Infect Dis· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profiling to predict and assess the consequences of therapy-induced virus eradication in chronic hepatitis C virus infection.
Jun Hou, Gertine van Oord, Zwier M A Groothuismink, Mark A A Claassen, Kim Kreefft

J Virol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controversy on the role of FoxP3⁺ regulatory T cells in fibrogenesis in chronic hepatitis C virus infections.
Mark A A Claassen, Harry L A Janssen, Robert J de Knegt, André Boonstra

J Hepatol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of T cell immunity in hepatitis C virus infections.
Mark A A Claassen, Harry L A Janssen, André Boonstra

Curr Opin Virol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Negative regulation of hepatitis C virus specific immunity is highly heterogeneous and modulated by pegylated interferon-alpha/ribavirin therapy.
Mark A A Claassen, Robert J de Knegt, Duygu Turgut, Zwier M A Groothuismink, Harry L A Janssen

PLoS One· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retention of CD4+ CD25+ FoxP3+ regulatory T cells in the liver after therapy-induced hepatitis C virus eradication in humans.
Mark A A Claassen, Robert J de Knegt, Harry L A Janssen, André Boonstra

J Virol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis